-
the updated variant classification for genetic disorders and will train members of the community on ClinGen processes for curating the scientific literature for gene curation. The work is done using the web
-
will identify, develop, and lead scientific strategies to support group goals and set direction for the group. The candidate is expected to work independently using their own ideas, knowledge, and
-
Role Summary The ADC Chemistry (AC) group is seeking a highly motivated, creative, and experienced medicinal chemist to develop novel payloads for antibody-drug conjugates (ADCs). You will apply
-
characterize and develop large and small molecules in close collaboration with partner lines as an integral member of the drug discovery teams. You will employ and develop cutting edge in vivo cancer models and
-
establishing an overall plan for maintaining fleet of NMR and Open Access NMR/Mass Spec/Spectroscopy instruments. You will develop new methods for using NMR and Mass Spec to drive drug discovery and you will
-
and active programs. How You Will Achieve It Plan and execute laboratory experiments to produce robust, decision-making data for the Discovery Neuroinflammation Group. Develop relevant in vitro assays
-
, sealants and functional coatings. With our trusted brands, our cutting-edge technologies and our disruptive solutions, you will have countless opportunities to explore new paths and develop your skills. Grow
-
systems with the expectation that they can provide immediate assistance, education, and training for colleagues, contractors, and visitors on an as needed basis. With your deep knowledge in the discipline
-
the performance characteristics of the assays, scale them up and develop automation strategies, and collaborate with multiple other teams to create high-throughput, validated, diagnostic assays in a regulated
-
technical expertise required for project progression. The individual will also work closely with the Medicinal Chemistry and Oncology Biology groups to innovate and develop the next-generation of therapies